Começar
ReutersReuters

Briacell Therapeutics’ Subsidiary, BriaPro, Files Patent Application For Immuno-Oncology Platform With Novel Multitargeting Agents

RefinitivMenos de 1 minuto de leitura
BCT

Briacell Therapeutics Corp BCT:

  • BRIACELL’S SUBSIDIARY, BRIAPRO, FILES PATENT APPLICATION FOR IMMUNO-ONCOLOGY PLATFORM WITH NOVEL MULTITARGETING AGENTS

Ações CanadensesAções EUAReuters
refinitivrefinitiv
© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html
Entrar ou criar uma conta gratuita para ler essa notícia

Mais notícias de Reuters